| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
* Max Delbrück Center for Molecular Medicine, Berlin, Germany; and
Institute of Immunology, Free University Berlin, Berlin, Germany
CD8+ effector T cells recognize malignant cells by monitoring their surface for the presence of tumor-derived peptides bound to MHC class I molecules. In addition, tumor-derived Ags can be cross-presented to CD8+ effector T cells by APCs. IFN-
production by CD8+ T cells is often critical for tumor rejection. However, it remained unclear whether 1) CD8+ T cells secrete IFN- in response to Ag recognition on tumor cells or APCs and 2) whether IFN- mediates its antitumor effect by acting on host or tumor cells. We show in this study that CD8+ effector T cells can reject tumors in bone marrow-chimeric mice incapable of cross-presenting Ag by bone marrow-derived APCs and that tumor rejection required host cells to express IFN-R. Together, CD8+ effector T cells recognize Ag directly on tumor cells, and this recognition is sufficient to reject tumors by IFN- acting on host cells.
This article has been cited by other articles:
|
|
 |
|
  E. Kieback, J. Charo, D. Sommermeyer, T. Blankenstein, and W. Uckert A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer PNAS, January 15, 2008; 105(2): 623 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, F. Pradera, T. Kammertoens, B. Li, S. Liu, and Z. Qin Cross-Talk between T Cells and Innate Immune Cells Is Crucial for IFN-{gamma}-Dependent Tumor Rejection J. Immunol., August 1, 2007; 179(3): 1568 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Dobrzanski, J. B. Reome, J. C. Hylind, and K. A. Rewers-Felkins CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer J. Immunol., December 1, 2006; 177(11): 8191 - 8201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Sercan, G. J. Hammerling, B. Arnold, and T. Schuler Cutting Edge: Innate Immune Cells Contribute to the IFN-{gamma}-Dependent Regulation of Antigen-Specific CD8+ T Cell Homeostasis J. Immunol., January 15, 2006; 176(2): 735 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Palmer, S. Balasubramaniam, K.-i. Hanada, C. Wrzesinski, Z. Yu, S. Farid, M. R. Theoret, L. N. Hwang, C. A. Klebanoff, L. Gattinoni, et al. Vaccine-Stimulated, Adoptively Transferred CD8+ T Cells Traffic Indiscriminately and Ubiquitously while Mediating Specific Tumor Destruction J. Immunol., December 15, 2004; 173(12): 7209 - 7216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Hollenbaugh, J. Reome, M. Dobrzanski, and R. W. Dutton The Rate of the CD8-Dependent Initial Reduction in Tumor Volume Is Not Limited by Contact-Dependent Perforin, Fas Ligand, or TNF-Mediated Cytolysis J. Immunol., August 1, 2004; 173(3): 1738 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Pappu and P. A. Shrikant Alteration of Cell Surface Sialylation Regulates Antigen-Induced Naive CD8+ T Cell Responses J. Immunol., July 1, 2004; 173(1): 275 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schuler, S. Kornig, and T. Blankenstein Tumor Rejection by Modulation of Tumor Stromal Fibroblasts J. Exp. Med., November 17, 2003; 198(10): 1487 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Qin, J. Schwartzkopff, F. Pradera, T. Kammertoens, B. Seliger, H. Pircher, and T. Blankenstein A Critical Requirement of Interferon {gamma}-mediated Angiostasis for Tumor Rejection by CD8+ T Cells Cancer Res., July 15, 2003; 63(14): 4095 - 4100. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
